In 2022, global pharmaceutical giant Pfizer and Korean pharmaceutical giant Samsung Biologics took the top spots in terms of sales, earning KRW 91 billion and KRW 2.437 trillion, respectively. in 2022, according to a new report released by the Korea Health Industry Development Institute,

According to the '2023 Health Industry Statistics' recently published by the Korea Health Industry Promotion Institue, sales in the domestic pharmaceutical industry totaled at KRW 37.69 trillion in 2022, up 12.8% year-on-year from KRW 33.42 trillion in the previous year.

On the other hand, R&D expenditures the companies invested company granted for each employee totaled at KRW 314.9 billion in the same year